Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Venetoclax in Combination With BEAM Conditioning Regimen for ASCT in Non-Hodgkin Lymphoma

NCT03713580

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

NCT00400946

Conditions: Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Drug/Agent Toxicity by Tissue/Organ, +11 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, United States

James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States

Albert Einstein Cancer Center at Albert Einstein College of Medicine The Bronx, New York, United States

View Trial Details

Completed

CMC-544 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)

NCT01134575

Conditions: Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL

NCT04263584

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: University Hospital RWTH Aachen Aachen, Germany

Haematology and Oncology Practice Augsburg, Germany

Klinikum-Bremen-Mitte Bremen, Germany

St.-Johannes-Hospital Dortmund Dortmund, Germany

View all 16 locations

View Trial Details

Completed

Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

NCT05927558

Conditions: B-cell Non Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
Locations: Ematologia Istituto Nazionale Tumori Milan, Italy

View Trial Details

Completed

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

NCT04975555

Conditions: Acute Lymphoblastic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +26 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

Rehabilitation Management for Patients With Multiple Myeloma

NCT06838065

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: AUSL-IRCCS of Reggio EmiliaOperational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia, Reggio Emilia, Emilia Romagna 42123 Reggio Emilia, Italy

View Trial Details

Completed

Primary Bone Mature B-Cell NHL in Children

NCT07721194

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: CHU NICE Nice, Alpes Maritimes, France

View Trial Details

Completed

Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL

NCT02337829

Conditions: Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +18 more
Locations: Research Site Bethesda, Maryland, United States

View Trial Details

Completed

FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

NCT05504811

Conditions: Brain Diseases, Central Nervous System Diseases, Cognition Disorders, +16 more
Locations: Rancho Research Institute, Inc Downey, California, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions